Pharmaceutical Price Regulation Scheme

(asked on 26th April 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that improving patient access to innovative new medicines is included in the terms of reference for negotiations on the pharmaceutical price regulation scheme.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 3rd May 2018

The current Pharmaceutical Price Regulation Scheme has seen the Department prioritise rapid access to innovative, new, cost-effective medicines that improve patient outcomes, including a provision for companies to propose Patient Access Schemes to help make sure these treatments can be made widely available in the National Health Service. This has been supported by a broader range of initiatives including the Cancer Drugs Fund and the new Accelerated Access Collaborative.

The Department will shortly be formally agreeing the structure and topics for negotiation with industry on the successor to the current Pharmaceutical Price Regulation Scheme, following the informal discussions which have already begun.

Reticulating Splines